RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes
RXi Pharmaceuticals Corporation | April 18, 2017
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced that Gerrit Dispersyn, Dr.